Communication Dans Un Congrès Année : 2023

Low miR-155, -29c, -132 or -100 predicts longer survival with bevacizumab plus chemotherapy in patients with pleural mesothelioma from MAPS trial

Fichier non déposé

Dates et versions

hal-04410467 , version 1 (22-01-2024)

Identifiants

  • HAL Id : hal-04410467 , version 1

Citer

Guénaëlle Levallet, Christian Creveuil, Alexandre Léger-Vigot, Solenn Brosseau, Claire Danel, et al.. Low miR-155, -29c, -132 or -100 predicts longer survival with bevacizumab plus chemotherapy in patients with pleural mesothelioma from MAPS trial. International Conference of the international Mesothelioma Interest Group, Jun 2023, Lille, France. ⟨hal-04410467⟩
74 Consultations
0 Téléchargements

Partager

  • More